Patient‐Centered GA Care: A Synergistic Approach to Optimize Management

The recent FDA approval of 2 novel therapies for the management of patients with geographic atrophy (GA) secondary to age-related macular degeneration has further reenforced the necessity for early GA diagnosis to limit progression. Advances in imaging technologies now provide tools for better detection and characterization of GA, along with biomarkers to monitor progression over time. Optometrists, as front-line eye healthcare providers, play a critical role in the timely diagnosis, management, and referral of patients with GA. In this 4-part podcast series, experts in optometry and retinal diseases evaluate imaging techniques and technologies that can improve the diagnosis and monitoring of patients with GA, assess the latest evidence for the use of therapeutic options that can improve GA management, and discuss optimal strategies for interprofessional collaboration in the care of these patients.